Q. What is The NET Alliance?
A. The NET Alliance is a long-term commitment by Novartis to patients and healthcare providers (HCPs) to improve patient outcomes by advancing the knowledge and management of neuroendocrine tumors (NETs).
Q. What will The NET Alliance do?
A. The NET Alliance is striving to transform the management of NETs through
- Diagnosis: Elevating disease awareness to facilitate diagnosis
- Management: Optimizing NET management strategies
- Patient support: Empowering NET patients to take an active role in their disease management
- Advancements in NET research: Growing the biologic and clinical understanding of NETs to advance future developments
Q. How will The NET Alliance help with diagnosis?
A. The NET Alliance will provide disease education, including data on prevalence and survival rates, information and tools to help shorten time to diagnosis, a clear understanding of the patient journey, and details of diagnostic testing options. Materials for both patients and HCPs will be available through The NET Alliance.